
Matrix Partners is an early-stage venture capital firm that invests in technology companies from the idea stage through Series A. They focus on backing founders building transformative technology across various sectors, including B2B, infrastructure, consumer technology, AI, fintech, digital health, and B2B SaaS.
Deal activity increased 300% year-over-year (8 deals in the last 12 months). Average disclosed round size is $77.3M (across 112 rounds with reported amounts).
Portfolio
117
Fund Size
$4B
Top Stage
Series B
Last 12 Mo
8
Team
James Olsen
Founder & Managing Partner
Kirk Konert
Managing Partner
Tim Barrows
General Partner
Travis Pearson
General Partner
Kojo Osei
Partner
Moody Nashawaty
Previously the CSO and Partner
Nathan Grossman
Partner
Roger McNamee
Partner
Ryan Sanders
Partner
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| GGiant | Seed | $8M | Feb 2026 |
| Seed | $10.5M | Dec 2025 | |
| Series C | $250M | Nov 2025 | |
| Series C | $900M | Nov 2025 | |
| Growth | $900M | Nov 2025 | |
| Series C | $60M | Jul 2025 | |
| GGeneral Medicine | Series A | $32M | May 2025 |
| Growth | $275M | Mar 2025 | |
| SSahara AI | Series B | $43M | Aug 2024 |
| Series B | $24M | Jun 2024 | |
| Series A | $50M | Jan 2024 | |
| Series B | $12.4M | Oct 2023 | |
| Series B | $60M | Sep 2023 | |
| Series D | $80M | Aug 2023 | |
| Series B | $24M | Jun 2023 | |
| EElevateBio | Growth | $401M | May 2023 |
| Series A | $10M | Jan 2023 | |
| SSolve Therapeutics, Inc. | Series A | $126M | Dec 2022 |
| CCommonGround | Series B | $25M | Nov 2022 |
| Series C | $25M | Nov 2022 | |
| Series A | — | Sep 2022 | |
| Series A | $13M | Sep 2022 | |
| Growth | $52M | Jul 2022 | |
| Series B | $35M | Jun 2022 | |
| Unknown | — | May 2022 |
Top Co-Investors
Last updated: 5 March 2026